Welcome
Based on our successful first edition in 2024, MD.be will organize its second Belgian cfDNA Oncology meeting on 26 November 2026 in the Pullman hotel in Brussels. The meeting aims to inform you about the latest developments in the fast-growing field of cfDNA analysis, with a focus on Belgian initiatives in research and diagnostics in oncology.
Organised by
09.30 - 10.50
Welcome
Extracellular RNA in biofluids: a tale of cancer biomarker tail genes
Dr. Jo VandesompeleGhent University
Multimodal cfDNA Profiling in Solid Tumours: Translating OncoXPLORE from Research to Clinical Diagnostics
Dr. Isabelle Vanden BemptUZ Leuven
NET-IMPRESS: A targeted methylation-based assay for circulating tumor DNA detection in neuroendocrine tumors
Dr. Ken Op de BeeckAntwerp University
Coffee break
11.15 - 12.15
Longitudinal cell-free DNA methylome and fragmentome profiles in health uncover signatures of cell type and demographic origin
Dr. Bernard ThienpontKU Leuven
Selected abstract 1
Selected abstract 2
Lunch
13.20 - 14.40
BRCA1 and BRCA2 analysis in prostate cancer
Astra Zeneca sponsored talkDr. Geert Martens & Dr. Henry Paridaens
ctDNA Clinical Applications Along the Colorectal Cancer Patient Journey
Dr. Remond FijnemanNKI Amsterdam
The NEOpredict-EGFR study: cfDNA dynamics and treatment response in lung cancer
Dr. Kristof CuppensJessa Hospital Hasselt
Coffee break
15.10 - 17.00
Selected abstract 3
Selected abstract 4
ctDNA in France – quality control, guidelines and CGP position
Dr. Etienne RouleauGustave Roussy Paris
Reception
Place Victor Horta 1, 1060 BRUSSELS, BELGIUM
Just next to the Brussels-Zuid / Bruxelles-Midi railway station.
Directions
Add this conference to your calendar
Organised by
Main sponsor
Co-sponsors
